Microfluidic Single-Cell Nucleic Acid Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for amplifying polynucleotides from single cells face challenges such as loss of original cellular material, risk of contamination, and amplification bias, particularly in bulk amplification setups where partitioning molecules into smaller droplets increases the risk of material loss and contamination.

Innovation Solution

A system and method that deposit a single cell directly into a microfluidic device capable of producing small droplets with necessary reactants for amplification, minimizing the risk of contamination and bias by using a device that creates a stream of single cells and forms emulsion droplets for precise polynucleotide amplification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If molecules from a single cell are partitioned into a plurality of smaller partitions (droplets) for separate processing, then amplification bias is minimized and each cell can be processed separately, but the risk of losing original cellular polynucleotide material and contamination increases due to multiple transfer steps

Engineering Contradiction:
Improveamplification uniformityVSAvoidmaterial loss and contamination risk
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent combines the cell deposition function and droplet generation function into a single integrated microfluidic device. Cells are deposited directly into the droplet formation chamber where amplification reactants are pre-loaded, eliminating the need for separate transfer steps between different containers. This merging of functions maintains the benefits of partitioning for reduced amplification bias while avoiding the material loss and contamination risks associated with multiple transfers.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microfluidic device serves as an intermediary platform that integrates multiple functions. It provides a controlled environment where cells are deposited, lysed, and where droplets are formed with amplification reactants all in one location. This intermediary structure enables precise control over the amplification process while minimizing the number of times material must be transferred between containers.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If bulk amplification is used to process multiple cells simultaneously, then processing efficiency is improved, but amplification bias occurs resulting in non-uniform sequence coverage

Engineering Contradiction:
Improveprocessing efficiencyVSAvoidsequence coverage uniformity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent segments the amplification process into separate droplets, each containing a single cell and amplification reactants. This segmentation allows parallel processing of multiple cells simultaneously (maintaining high productivity) while ensuring uniform amplification conditions for each individual cell, thereby eliminating amplification bias and achieving uniform sequence coverage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Each droplet creates a localized amplification environment with controlled conditions specific to that single cell. This local quality approach ensures that each cell undergoes identical amplification treatment while being processed in parallel, achieving both high efficiency and uniformity.

Inventive Principle:
Principle #3Local quality

3Adaptability or versatility

If multiple transfer steps are used to move cellular polynucleotide material between containers, then flexibility in processing is improved, but the risk of losing original cellular polynucleotide material and contamination increases

Engineering Contradiction:
Improveprocessing flexibilityVSAvoidpolynucleotide material loss
Core Design Contradiction:
Adaptability or versatilityVSLoss of substance

Solution Approach 1:

The patent merges the cell deposition, lysis, and droplet formation steps into a single integrated microfluidic device. Cells are deposited directly into the device where they are immediately lysed and incorporated into droplets with amplification reactants. This eliminates multiple transfer steps and maintains processing flexibility through the microfluidic system's programmable control over cell deposition and droplet formation.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution effectively reduces the loss of original cellular material and minimizes contamination and amplification bias, achieving more uniform and sensitive polynucleotide amplification with improved sequence coverage and specificity.

Implementation Method 1

a microfluidic device that is capable of producing an emulsion of droplets

Methodology Applied
Scientific EffectEmulsion: Emulsion

Data Source

PatentUS20220275434A1System and method for amplifying nucleic acids from single cells
Publication Date: 2022.09.01 SAMPLIX APS
  • US20220275434A1 patent drawing
  • US20220275434A1 patent drawing
  • US20220275434A1 patent drawing

AI summary

The present invention relates to a system for amplification of polynucleotides from a predefined number of single cells. The system comprise a device (or part) providing the predefined number of single cells, at a previously defined inlet site (or orifice) of a cartridge (microfluidic device), and the cartridge itself. The invention further relates to a method for amplification of polynucleotides from the one or more single cells using the system to provide an emulsion of aqueous droplets wherein the nucleic acid amplification occurs. Furthermore, the present invention relates to a kit comprising a plurality of microfluidic devices and a plurality of fluids configured for use with the system and the method.